Context Therapeutics Inc (CNTX)
2.00
-0.01
(-0.50%)
USD |
NASDAQ |
Jun 28, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Price to Book Value: 17.77 for June 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 27, 2024 | 17.85 |
| June 26, 2024 | 17.59 |
| June 25, 2024 | 19.45 |
| June 24, 2024 | 19.36 |
| June 21, 2024 | 19.19 |
| June 20, 2024 | 19.28 |
| June 18, 2024 | 17.94 |
| June 17, 2024 | 17.23 |
| June 14, 2024 | 17.41 |
| June 13, 2024 | 17.50 |
| June 12, 2024 | 17.77 |
| June 11, 2024 | 18.21 |
| June 10, 2024 | 17.14 |
| June 07, 2024 | 15.19 |
| June 06, 2024 | 15.54 |
| June 05, 2024 | 15.81 |
| June 04, 2024 | 16.08 |
| June 03, 2024 | 18.12 |
| May 31, 2024 | 17.59 |
| May 30, 2024 | 17.77 |
| May 29, 2024 | 17.77 |
| May 28, 2024 | 18.12 |
| May 24, 2024 | 17.77 |
| May 23, 2024 | 17.32 |
| May 22, 2024 | 17.32 |
| Date | Value |
|---|---|
| May 21, 2024 | 18.03 |
| May 20, 2024 | 17.68 |
| May 17, 2024 | 17.77 |
| May 16, 2024 | 15.99 |
| May 15, 2024 | 15.01 |
| May 14, 2024 | 15.19 |
| May 13, 2024 | 14.92 |
| May 10, 2024 | 16.61 |
| May 09, 2024 | 16.26 |
| May 08, 2024 | 16.08 |
| May 07, 2024 | 15.28 |
| May 06, 2024 | 15.81 |
| May 03, 2024 | 3.498 |
| May 02, 2024 | 3.309 |
| May 01, 2024 | 2.572 |
| April 30, 2024 | 2.542 |
| April 29, 2024 | 2.591 |
| April 26, 2024 | 2.666 |
| April 25, 2024 | 2.610 |
| April 24, 2024 | 2.458 |
| April 23, 2024 | 2.666 |
| April 22, 2024 | 2.572 |
| April 19, 2024 | 2.496 |
| April 18, 2024 | 2.666 |
| April 17, 2024 | 2.628 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.256
Minimum
Dec 28 2022
19.45
Maximum
Jun 25 2024
1.799
Average
0.7175
Median
Price to Book Value Benchmarks
| Emergent BioSolutions Inc | 0.5375 |
| AbbVie Inc | 37.81 |
| Revance Therapeutics Inc | -- |
| Design Therapeutics Inc | 0.6958 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 2.00 |
| Earnings Yield | -66.50% |
| Market Cap | 150.00M |